title: [Haemorrhage delivery. About 65 cases].
abstract: The delivery haemorrhage is actually a problem of public health. It is responsible of 31.5 % of the maternal death in Tunisia. The goal of this work is to study the frequency of this complication, its gravity, its risk factors, its etiologists and its methods of treatment. It is a retrospective study. of 65 cases of delivery haemorrhage recorded to the obstetric gynaecology service "C" of the centre of motherhood and neonatology of Tunis during 4 years. The frequency of the delivery haemorrhage in our study is 1.19%. The middle age of the patient is of 31 years. Their middle parity is 2.4. Factors of risk taking out again our set are: gestational toxemia (35.4%), primiparity (33.8%), advanced maternal age (30.7%), pre-existent anaemia (24.6%). the uterine surdistension (21.3%), an abnormal middle length of labour (69.6%). use of oxytocin during labour (34%), induction (21.5%). Etiologists in our set are: atone in 63% of cases, retained placenta in 31.2% des cases, coagulopathie (9.2%), placenta previa (1.5%), uterine inversion (1.5%). The hold must be in charge multidisciplinary, systematized, precocious and dynamic.
authors.affiliation: Service C- Centre de la maternité et de néonatologie de Tunis.
authors.forename: Rim
authors.initials: R
authors.lastname: Ben Hmid
authors.forename: Sonia
authors.initials: S
authors.lastname: El Houssaini
authors.forename: Sami
authors.initials: S
authors.lastname: Mahjoub
authors.forename: Mecheal
authors.initials: M
authors.lastname: Mourali
authors.forename: Dorra
authors.initials: D
authors.lastname: Zeghal
authors.forename: Faouzia
authors.initials: F
authors.lastname: Zouari
authors.forename: Moez
authors.initials: M
authors.lastname: El Kamel
authors.forename: Mourad
authors.initials: M
authors.lastname: Bouchnek
authors.forename: Hayen
authors.initials: H
authors.lastname: Maghrebi
mesh_terms: D000328:Adult; D000367:Age Factors; D000740:Anemia / Q000453:epidemiology; D001778:Blood Coagulation Disorders / Q000453:epidemiology; D005260:Female; D006801:Humans; D007748:Labor Stage, Second; D008423:Maternal Age; D010120:Oxytocics / Q000627:therapeutic use; D010121:Oxytocin / Q000627:therapeutic use; D010298:Parity; D018457:Placenta, Retained / Q000453:epidemiology; D006473:Postpartum Hemorrhage / Q000453:epidemiology*; D011225:Pre-Eclampsia / Q000453:epidemiology; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D014416:Tunisia / Q000453:epidemiology; D014593:Uterine Inertia / Q000453:epidemiology
chemical_list: D010120:Oxytocics; D010121:Oxytocin